Feds Investigate Off-Label ICD Reimbursement
This article was originally published in The Gray Sheet
Executive Summary
Another potentially relevant factor in off-guideline ICD use is whether Medicare is paying for the procedure and whether the payment is appropriate under current coverage policies. The Department of Justice is investigating inappropriate Medicare reimbursement for ICDs, and this study could at minimum provide momentum to that effort, an industry analyst suggests.
You may also be interested in...
Cardiac Rhythm Management Market Faces Continued Challenges Ahead
The CRM market is facing continued growth challenges as manufacturers struggle to jumpstart lagging sales and broaden adoption of implantable cardioverter defibrillators and cardiac resynchronization therapy devices while facing a brewing storm in the US over appropriate device use.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.